- A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study The Lancet
- Leiden study shows adjusting drug doses to patient DNA cuts side effects – DutchNews.nl DutchNews.nl
- Matching medicine dosage to patient’s DNA can cut side effects 30%: LUMC NL Times
- View Full coverage on Google News
